We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Microarray Chip Rapidly Detects Dengue Fever

By LabMedica International staff writers
Posted on 21 Jul 2014
Print article
Image: A cDNA microarray on a chip for rapid detection of dengue fever (Photo courtesy of Investigación y Desarrollo).
Image: A cDNA microarray on a chip for rapid detection of dengue fever (Photo courtesy of Investigación y Desarrollo).
A chip has been developed that allows for the detection of the ribonucleic acid (RNA) strand of the virus that causes dengue fever, now endemic in 110 countries.

The chip allows analysis of the complementary strand of DNA (cDNA) obtained from the dengue fever virus being carried by the infected patient and the cDNA is covalently linked to a slide or substrate that can be a glass or paper.

Scientists at the Center for Research and Advanced Studies (Cinvestav; Mexico City, Mexico) used probes marked with fluorescent elements, called fluorochromes that can distinguish in the chip different colors according to the serotype of dengue fever the patient is carrying. Additionally, the cDNA microarray can display more than one color if the patient carries two serotypes.

The scientists said that knowing the precise serotype of dengue fever virus the patient is carrying, the progression of the disease would stop and an optimal follow up of the treatment would be held. There are five strains of the virus, called serotypes, of which the first four are referred to as DENV-1, DENV-2, DENV-3 and DENV-4 and the distinctions between the serotypes is based on their antigenicity. If a painkiller or an antihistamine are prescribed to the patient infected by the dengue virus, such drugs could cause a thinning of the blood vessels walls, thus triggering hemorrhagic fever.

Maria de Lourdes Muñoz Moreno, PhD, a senior scientist, at the Department of Genetics and Molecular Biology at Cinvestav, said, “When it comes to a second infection with another serotype, the antibodies that protect the body from dengue fever in the first infection, could now adhere to the virus of a new serotype, causing the cells to be more easily infected.” The group at Cinvestav is working to achieve a microarray that differentiates dengue fever from Chikungunya, a viral disease recently reported in Latin America that is transmitted in a dengue-like manner, causing an acute febrile phase lasting two to five days.

Related Links:

Center for Research and Advanced Studies


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.